FromAstraZeneca ([email protected])
Sent withMailchimp
Subject (48)Datroway recommended for approval in EU for TNBC
Preheader (150)Datroway recommended for approval in the EU by CHMP as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candi
Typography
Arial
Colors
Text Analysis
Body Words147
Subject Words8
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px778 px
X-Spam Score1.6
Preheader OptimizedNo
Timing
Day of WeekMonday
TimeOvernight

Datroway recommended for approval in EU for TNBC

Datroway recommended for approval in the EU by CHMP as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candi
Datroway recommended for approval in EU for TNBC